Abu Dhabi, UAE, November 26th, 2022 – Infusion 51a, an impact investment fund based in the US in its fourth trip to the Middle East this year, attended on Saturday, November 26th the 10th Emirates Oncology Conference in Abu Dhabi, UAE, held at the Conrad Etihad Towers.
The 10th Emirates Oncology Conference is a three-day event that has established itself as one of the premier medical conferences in the region and is increasingly being recognized as one of the leading oncology conferences in the global healthcare calendar.
With a world-class line-up of renowned speakers, leaders, and experts in the various fields of cancer diagnosis, treatment, and research, it highlights the significant advances that have been made in science and clinical practice.
Mr. Scott VanderMeer, General Partner at Infusion 51a, shared in an official statement: “This was an inspiring meeting point for us. Doctors, scientists, researchers, KOL’s and decision makers all converged in the same place for three days and the result was phenomenal. We look forward to being part of next year’s edition.”
Likewise, Mr. Mehrab Ajalli, Director of Strategic Growth in the MENA Region, commented: “Our impressions of the Emirates Oncology Conference are exceptional. They accomplished their goal of reuniting the best of the best with a focus of improving the lives of patients with cancer around the world.”
For the fourth time this year, Infusion 51a’s US leadership is on a business trip in the Middle East. Mr. VanderMeer and Mr. Ajalli will be in different cities in the UAE and Saudi Arabia to attend further meetings and conferences during November and early December.
Upcoming events and locations
- International Indo-Arab Conference in Medicine 2022 (Nov 27) (Invited by his HE Ahmed Elmetwally) | Dubai
- Hosting meetings (Nov 28-30) | Dubai
- Hosting meetings (Dec 2-6) | Saudi Arabia
Infusion 51a expanded its operations to the Middle East during the first quarter of 2022 and has been working closely with top-tier institutions to bolster healthcare technology in the Region. If you would like to have an in-person meeting with them to learn how Infusion 51a can help you, click here.
About Infusion 51a
Infusion 51a is an impact investment fund focused on Healthcare and Biotech while leveraging the booming industry of Precision Technology. Precision Technology is a turning point within the Healthcare sector, with digital technologies and artificial intelligence leading to unprecedented opportunities for drug discovery and development. The fund has several oncological assets under management derived from its diversified portfolio of clinical-stage companies.
About Emirates Oncology Conference
Emirates Oncology Conference is one of the largest health-related conferences in the region with delegates attending from around the Middle East and GCC region.
The conference not only brings together international and local expertise in cancer care and management but also offers to the companies the opportunity to showcase their products and services to the largest gathering of healthcare professionals from the region.
For more information, please visit https://emiratesoncology.ae or download the brochure https://emiratesoncology.ae/wp-content/uploads/2022/11/EOC-2022-E-Brochure.pdf.